Summary

The QuickScan Gen II Goniometer is a groundbreaking innovation in the field of physical therapy that has revolutionized the way patients can detect and monitor their hand range of motion (ROM) from the comfort of their own homes. Developed by QuickTech Medical, a biomedical company focused on enhancing patient rehabilitation, the Gen II Goniometer has introduced a new level of convenience, accuracy, and efficiency to ROM measurement.

Unlike traditional methods that rely on analog goniometers, which are known for their inaccuracy, inefficiency, and discomfort, the QuickScan Gen II Goniometer utilizes a sophisticated cradle device equipped with multiple hand trackers. This advanced technology allows patients to effortlessly place their arm in the cradle, enabling precise and real-time tracking of their hand's ROM. The data collected by the goniometer can be easily transmitted to healthcare providers and integrated into electronic health record (EHR) systems for comprehensive analysis and monitoring.

The key advantage of the QuickScan Gen II Goniometer lies in its ability to empower patients to monitor their ROM at home, reducing the frequency of visits to physical therapy clinics. By offering this capability, patients have gained greater flexibility and independence in managing their rehabilitation process. This revolutionary approach not only minimizes the burden on physical therapists by freeing up valuable in-office time, but it also enhances patient adherence and compliance to prescribed at-home exercises.

The QuickScan Gen II Goniometer has undergone rigorous clinical testing, validating its efficacy and accuracy in measuring ROM. The results have demonstrated its reliability and suitability for clinical use, providing both patients and healthcare providers with confidence in its performance. The technology behind the Gen II Goniometer is currently patent-pending, highlighting its innovative nature and unique position within the market.

My Contribution

During my tenure from 2018 to 2021 as the leader and founder of Radian Health, I played a pivotal role in the development and success of the QuickScan Gen II Goniometer. As the business development officer and marketing director, I actively contributed to various aspects of the project, utilizing my skills and expertise as a product manager. On the business side, I built and nurtured relationships with investors, mentors, and key stakeholders, effectively communicating the vision and potential of the QuickScan Gen II Goniometer. Through my efforts, I secured the necessary financial support and guidance to drive its development and commercialization.

Additionally, I took the lead in preparing and submitting essential documents, including the 104-page NIH SBIR grant application and the 84-page patent application. These meticulous efforts were instrumental in securing funding and protecting the intellectual property of the Gen II Goniometer, ensuring its competitive edge in the market.

Facilitating the development and clinical testing of the Gen II Goniometer, I collaborated closely with the development team, providing valuable insights and guidance throughout the product lifecycle. My contributions encompassed strategic decision-making, resource allocation, and ensuring alignment with the overall goals and vision of the project.

Furthermore, I had the privilege of representing the QuickScan Gen II Goniometer at prestigious events and competitions. I pitched in front of the king at the Bangkok Business Challenge, participated in the Schultze Business Challenge in Minneapolis, and had the opportunity to pitch at the canceled 2020 SXSW. These engagements effectively showcased the product's potential and garnered recognition for its innovation and impact.

Overall, my comprehensive involvement in the business, development, and marketing aspects of the QuickScan Gen II Goniometer from 2018 to 2021 was vital in bringing this groundbreaking product to fruition. Through my leadership, strategic efforts, and dedication as a product manager, I made significant contributions to its success.

QuickScan Gen II by Radian Health